Up by around 0.3%, the Paris Bourse starts the session rather confident for a session that should be largely dominated by the release of the official US employment report for September.

Due to be released in the early afternoon, "the report could strongly affect expectations for monetary policy", warns Duc Nam Pho, at Kama Capital, recalling that "the labor market remains resilient and is closely monitored by the Federal Reserve".

Weaker-than-expected labor market data could support stock market performance and a pullback in yields, as traders may incorporate a softer stance from the Federal Reserve', he continues.

As an indication, Jefferies expects the creation of 150.000 non-farm payrolls in September, down from 187,000 the previous month, with the unemployment rate dropping from 3.8% to 3.6% month-on-month.

While waiting for this week's key event, traders took note early this morning of the French trade balance and German industrial orders for August.

In August 2023, France's trade balance deteriorated slightly according to CVS-CJO data from the customs administration, with the deficit rising to 8.2 billion euros after 8.1 billion in July.

After plunging by 11.3% in July (revised from a provisional estimate of -11.7%), German industrial orders rebounded by 3.9% in August compared with the previous month, according to seasonally and calendar-adjusted data.

On the stock front, Renault and Volvo are to set up a company dedicated to the development of a brand-new generation of electric vans. CMA CGM will also join the new company.

This new all-electric Software-Defined Vehicle (SDV) range will be launched by the new company. Production is scheduled to start in 2026.

Crédit Agricole, having received all the necessary authorizations from the supervisory authorities, announces the launch of a program to buy back up to 26,835,641 shares between now and January 26, with a view to their cancellation.

Valeo announces the completion of its inaugural €600 million green bond issue, to which the European Investment Bank (EIB) has subscribed for €150 million.

According to Bloomberg, Sanofi is considering the acquisition of Mirati Therapeutics. This company specializes in the development of anti-cancer products. The company is developing several products in the clinic, including two Ph III studies and five Ph II studies, as monotherapy or in combination in various cancer indications," says Invest Securities.

Copyright (c) 2023 CercleFinance.com. All rights reserved.